I see the positives relating to Balchem''s recent deals, but I am concerned about the potential rise in costs and resulting lower profitability for the company in the very near term.
Specialty ingredients company Balchem (BCPC) is acquiring Cardinal Associates, operating as Bergstrom Nutrition.Bergstrom Nutrition is set to be included in Balchem''s human nutrition…
NEW HAMPTON, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredients company focused on Nutrition and Health, today announced the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
Smart Foods Market 2022-2028 Edison, NJ -- ( SBWIRE ) -- 08/22/2022 -- The Latest research study released by HTF MI "Smart Foods Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are Cargill Inc., Arla Foods, Kerry Group, Nestle, Archer Daniels Midland Company, Aveka, Balchem Corporation, GSK, Firmenich, BASF, Kellogg, The Coca Cola Company, Ingredion Inc., International Flavors & Fragrances Inc., PepsiCo, Royal FrieslandCampina N.V., Sensient Technologies Corporation, Symrise & Tate & Lyle etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3756901-smart-foods-market-1 Browse market information, tables and figures extent in-depth TOC on "Smart Foods Market by Application (Supermarket, Convenience Store, Online Stores & Others), by Product Type (, Functional Food, Encapsulated Food, Genetically Modified Food & Others), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at sales@htfmarketreport.com At last, all parts of the Smart Foods Market are quantitatively also subjectively valued to think about the Global just as regional market equally.
The S&P 500 Materials index closed this trading week with a slight dip of 0.58%
BCPC earnings call for the period ending June 30, 2022.
Balchem Corporation (NASDAQ:NASDAQ:BCPC) Q2 2022 Earnings Conference Call July 29, 2022 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman,…
The following slide deck was published by Balchem Corporation in conjunction with their 2022 Q2 earnings call.
Balchem (NASDAQ: BCPC ) reported its Q2 earnings results on Friday, July 29, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Balchem beat estimated earnings by 7.0%, reporting an EPS of $1.07 versus an … Full story available on Benzinga.com
Balchem press release (BCPC): Q2 Non-GAAP EPS of $1.07 beats by $0.07.Revenue of $236.7M (+17.0% Y/Y) beats by $13.17M.
Balchem (BCPC) is scheduled to announce Q2 earnings results on Friday, July 29th, before market open.The consensus EPS Estimate is $1.00 (+7.5% Y/Y) and the consensus Revenue Estimate…
Balchem (NASDAQ: BCPC ) is set to give its latest quarterly earnings report on Friday, 2022-07-29. Here''s what investors need to know before the announcement. Analysts estimate that Balchem will report an earnings per share (EPS) of $1.00. Balchem bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
Balchem is a long-term winner, driven by sound capital allocation and a strong positioning of the business. Read here to learn more about BCPC stock.
Balchem Corp. (BCPC) shares closed today at 1.8% above its 52 week low of $112.58, giving the company a market cap of $3B. The stock is currently down 32.6% year-to-date, down 14.8% over the past 12 months, and up 45.1% over the past five years. This week, the Dow Jones Industrial Average fell 7.2%, and the S&P 500 fell 8.7%. Trading Activity Trading volume this week was 55.7% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -5.5% The company's stock price performance over the past 12 months beats the peer average by -48.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 14.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Balchem (BCPC) signed a definitive agreement to acquire Oslo, Norway-headquartered Kappa Bioscience, science-based manufacturer of specialty vitamin K2 for the human…
Balchem deleveraged balance sheet completely and new growth phase is in front. See why I believe current correction in BCPC stock represents a good entry point.
The following slide deck was published by Balchem Corporation in conjunction with their 2022 Q1 earnings call.
NEW HAMPTON, N.Y., July 16, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, July 30 at 11:00 AM Eastern Time (ET) to review second quarter results. Ted Harris, Chairman of the Board, CEO and President, and Martin Bengtsson, CFO will host the call.
Balchem Corp. (BCPC) shares closed today at 1.2% below its 52 week high of $134.58, giving the company a market cap of $4B. The stock is currently flat year-to-date, up 41.0% over the past 12 months, and up 124.7% over the past five years. This week, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 2.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date is the same as the peer average. The company's stock price performance over the past 12 months lags the peer average by -10.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -16.6% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The report on Metam Sodium Market added by Affluence provides a complete briefing on strategic recommendations, trends, segmentation, use case analysis, competitive intelligence, global and regional forecast to 2026. The objective of this research is to provide a 360 holistic view of the Metam Sodium market and bringing insights that can help stakeholders identify the []
DUBLIN--(BUSINESS WIRE)--The "Choline Chloride Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com''s offering. The market for choline chloride was valued at USD 507.42 million in 2020 and is expected to grow at a CAGR of 4.11% during the forecast period (2021-2026). Companies Mentioned ALGRY Quimica SL BALAJI AMINES Balchem Corporation BASF SE Eastman Chemical Company GHW International Impextraco NV IMPERIAL GROUP LIMITED Jubila
ResearchCMFE has added a new research report on Food Encapsulation Market. The study aims to provide a roadmap of the Food Encapsulation industry which makes up for the scope of product, market revenue cycle, new opportunities, CAGR, sales volumes, and figures. The market analysts who authored this report have provided detailed information about key growth []
A report was released recently that sheds lots of light on the Pharmaceutical Encapsulation Technology Industry. The report covers an overview of the industry along with a detailed explanation that provides a lot of insight. The report also analyzes the production as well as management technology in various end-user industries. An in-depth study in some []
Global Dietary Supplements Personalized Nutrition Market The global Dietary Supplements Personalized Nutrition Market has been comprehensively analyzed and the results are presented in the market report published. The market concentration that is currently occupied by the Dietary Supplements Personalized Nutrition market and an overview of the Dietary Supplements Personalized Nutrition manufacturing industry is extensively researched []
Balchem Corp. (BCPC) shares closed today at 2.0% below its 52 week high of $134.58, giving the company a market cap of $4B. The stock is currently up 14.5% year-to-date, up 33.9% over the past 12 months, and up 126.1% over the past five years. This week, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 0.3%. Trading Activity Trading volume this week was 19.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -4.1% The company's stock price performance over the past 12 months lags the peer average by -22.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -14.2% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Pharmaceutical Encapsulation Technology Market Size, Status and Forecast 2021-2027 The report on the global Pharmaceutical Encapsulation Technology Market is derived from intense research, conducted by a team of industry professionals. The report covers briefly the products or services in the market
Latest survey report on Global Nutrition and Supplements Market sheds lights on changing dynamics in Food & Beverages Sector and elaborates market size and growth pattern of each of Nutrition and []
NEW HAMPTON, N.Y., May 18, 2021 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Stephens Food & Ag Disrupted: Public-Private Conference on May 25, 2021. Balchems presentation will begin at 9:00 a.m. (ET).
Balchem Corp. (BCPC) shares closed 0.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 13.2% year-to-date, up 50.3% over the past 12 months, and up 117.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 165.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -19.2% The company's stock price performance over the past 12 months lags the peer average by -19.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 28.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Balchem Corporation shares closed today at 1.4% below its 52 week high of $132.50, giving the company a market cap of $4B. The stock is currently up 13.4% year-to-date, up 44.4% over the past 12 months, and up 122.1% over the past five years. This week, the Dow Jones Industrial Average rose 4.1%, and the S&P 500 rose 2.7%. Trading Activity Trading volume this week was 15.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 60.5% The company's stock price performance over the past 12 months lags the peer average by -40.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 37.8% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
H.C. Wainwright Stick to Their Buy Rating for Balchem Corp.
Companies Reporting Before The Bell • Arbor Realty Trust (NYSE:ABR) is projected to report quarterly earnings at $0.45 per share on revenue of $42.55 million. • Barnes Gr (NYSE:B) is expected to report quarterly earnings at $0.33 per share on revenue of $282.78 million. • Balchem (NASDAQ:BCPC) is expected to report quarterly earnings at $0.80… Read More »Earnings Scheduled For February 19, 2021
Balchem (NASDAQ:BCPC) unveils its next round of earnings this Friday, February 19. Here is Benzinga's everything-that-matters guide for the earnings …
Balchem announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
Balchem (NASDAQ:BCPC) is scheduled to release its earnings data before the market opens on Wednesday, October 28th. Analysts expect Balchem to post earnings of $0.67 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Balchem (NASDAQ:BCPC) last issued its quarterly earnings results […]
Balchem (NASDAQ:BCPC) was upgraded by stock analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Tuesday, BidAskClub reports. Other equities research analysts have also issued reports about the stock. HC Wainwright lifted their price target on shares of Balchem from $104.00 to $126.00 and […]
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 31, 2020 New Hampton, New York. July… | July 20, 2020
Balchem (BCPC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Blachem (BCPC) delivered earnings and revenue surprises of 37.29% and 2.61%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
DUBLIN, April 24, 2020 /PRNewswire/ -- The "Global Personalized Nutrition Market Analysis & Trends - Industry Forcast to 2028" report has been added to ResearchAndMarkets.com's offering. The Global Personalized Nutrition Market is poised to grow strong during the forecast period 2018 to…
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blachem (BCPC) delivered earnings and revenue surprises of 10.00% and -4.60%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Blachem (BCPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blachem (BCPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Balchem Corp (NASDAQ:BCPC) Q1 2019 Results Conference Call May 03, 2019 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris -
BCPC earnings call for the period ending March 31, 2019.
Balchem Corporation (NASDAQ: BCPC ) announced Thursday that it signed a definitive agreement to acquire Chemogas NV, a privately held specialty gases company based in Grimbergen, Belgium. What Happened Balchem is buying Chemogas from the company's management and from Glide Equity Management, a private equity firm focused on the Benelux region — Belgium, Netherlands and Luxembourg. The amount of the transaction was not disclosed; it will be financed with Balchem's existing revolving credit facility and … Full story available on Benzinga.com
Blachem (BCPC) delivered earnings and revenue surprises of 5.80% and -4.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Balchem (BCPC): Q1 Non-GAAP EPS of $0.73 in-line; GAAP EPS of $0.58. Revenue of $157.03M (-2.7% Y/Y) misses by $8.54M. Press Release